Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Multiple Myeloma 7 Lymphoma 5 Lymphoma, B-Cell, Marginal Zone 4 Stomach Neoplasms 3 Neoplasms, Plasma Cell 2 Dyspepsia 2 Recurrence 1 Peptic Ulcer 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Gastritis 1 B-cell Malignancies 1

Interventions

ofatumumab 10 Rituximab 6 ibrutinib 5 Cyclophosphamide 5 fludarabine phosphate 4 Bendamustine Hydrochloride 4 fludarabine 3 Lenalidomide 3 Alemtuzumab 3 spebrutinib 2 navitoclax 2 acalabrutinib 2 KW-2478 2 venetoclax 1 tirabrutinib 1 obinutuzumab 1 idelalisib 1 dinaciclib 1 Tablets 1 Stem Cell Transplantation 1 Rabeprazole 1 Pentostatin 1 Metronidazole 1 Methylprednisolone 1 Magnetic Resonance Imaging 1 MLN 8237 1 Leukapheresis 1 Lansoprazole 1 Itraconazole 1 Immunotherapy, Adoptive 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Leukemia, B-Cell × Clarithromycin × Clear all

NCT01279252 2019-01-25

CLEAR

King's College Hospital NHS Trust

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡